Clinical and biological significance of miR-378a-3p and miR-378a-5p in colorectal cancer

European Journal of Cancer

Volumn 50, Issue 6, 2014, Pages 1207-1221

  Li, Hui ^a   Dai, Sujuan ^a   Zhen, Tiantian ^a   Shi, Huijuan ^a   Zhang, Fenfen ^a   Yang, Yang ^a   Kang, Lili ^a   Liang, Yingjie ^a   Han, Anjia ^a  

^a SUN YAT SEN UNIVERSITY   (China)

Author keywords

Colorectal cancer; Insulin like growth factor 1 receptor; MiR 378a 3p; MiR 378a 5p

Indexed keywords

MICRORNA; MICRORNA 378A 5P; MIRNA 378A 3P; MITOGEN ACTIVATED PROTEIN KINASE 1; MITOGEN ACTIVATED PROTEIN KINASE 3; PROTEIN KINASE B; SOMATOMEDIN C RECEPTOR; UNCLASSIFIED DRUG;

ADULT; APOPTOSIS; ARTICLE; CANCER CELL CULTURE; CANCER STAGING; CELL INVASION; CELL MIGRATION; CELL PROLIFERATION; CLINICAL FEATURE; COLONY FORMATION; COLORECTAL CANCER; CONTROLLED STUDY; FEMALE; G1 PHASE CELL CYCLE CHECKPOINT; GENE EXPRESSION; HISTOPATHOLOGY; HUMAN; HUMAN CELL; HUMAN TISSUE; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROTEIN EXPRESSION; RNA ANALYSIS; SURVIVAL TIME; TUMOR DIFFERENTIATION; TUMOR SUPPRESSOR GENE; TUMOR VOLUME;

COLORECTAL CANCER; INSULIN-LIKE GROWTH FACTOR 1 RECEPTOR; MIR-378A-3P; MIR-378A-5P;

ADULT; AGED; AGED, 80 AND OVER; APOPTOSIS; BLOTTING, WESTERN; CELL LINE, TUMOR; CELL PROLIFERATION; COLORECTAL NEOPLASMS; FEMALE; GENE EXPRESSION REGULATION, NEOPLASTIC; HCT116 CELLS; HT29 CELLS; HUMANS; MALE; MICRORNAS; MIDDLE AGED; MITOGEN-ACTIVATED PROTEIN KINASE 1; MITOGEN-ACTIVATED PROTEIN KINASE 3; NEOPLASM STAGING; PHOSPHORYLATION; PROGNOSIS; RECEPTOR, IGF TYPE 1; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; SURVIVAL ANALYSIS; YOUNG ADULT;

EID: 84897086933     PISSN: 09598049     EISSN: 18790852     Source Type: Journal    
DOI: 10.1016/j.ejca.2013.12.010     Document Type: Article

References (21)

1. J. Weitz, M. Koch, J. Debus, T. Hohler, P.R. Galle, and M.W. Buchler Colorectal cancer Lancet 365 9454 2005 153 165
2. M. Li, J. Li, X. Ding, M. He, and S.Y. Cheng MicroRNA and cancer AAPS J 12 3 2010 309 317
3. B. Zhang, X. Pan, G.P. Cobb, and T.A. Anderson MicroRNAs as oncogenes and tumour suppressors Dev Biol 302 1 2007 1 12
4. N. Lynam-Lennon, S.G. Maher, and J.V. Reynolds The roles of microRNA in cancer and apoptosis Biol Rev Camb Philos Soc 84 1 2009 55 71
5. M. Feng, Z. Li, M. Aau, C.H. Wong, X. Yang, and Q. Yu Myc/miR-378/TOB2/cyclin D1 functional module regulates oncogenic transformation Oncogene 30 19 2011 2242 2251
6. Q.P. Wu, Y.Z. Xie, Z. Deng, X.M. Li, W. Yang, and C.W. Jiao et al. Ergosterol peroxide isolated from Ganoderma lucidum abolishes microRNA miR-378-mediated tumor cells on chemoresistance PLoS One 7 8 2012 e44579
7. L.T. Chen, S.D. Xu, H. Xu, J.F. Zhang, J.F. Ning, and S.F. Wang MicroRNA-378 is associated with non-small cell lung cancer brain metastasis by promoting cell migration, invasion and tumor angiogenesis Med Oncol 29 3 2012 1673 1680
8. J. Qian, J. Lin, W. Qian, J.C. Ma, S.X. Qian, and Y. Li et al. Overexpression of miR-378 is frequent and may affect treatment outcomes in patients with acute myeloid leukemia Leuk Res 37 7 2013 765 768
9. M. Redova, A. Poprach, J. Nekvindova, R. Iliev, L. Radova, and R. Lakomy et al. Circulating miR-378 and miR-451 in serum are potential biomarkers for renal cell carcinoma J Transl Med 10 2012 55
10. H. Liu, L. Zhu, B. Liu, L. Yang, X. Meng, and W. Zhang et al. Genome-wide microRNA profiles identify miR-378 as a serum biomarker for early detection of gastric cancer Cancer Lett 316 2 2012 196 203
11. M. Sand, M. Skrygan, D. Sand, D. Georgas, S.A. Hahn, and T. Gambichler et al. Expression of microRNAs in basal cell carcinoma Br J Dermatol 167 4 2012 847 855
12. L. Scapoli, A. Palmieri, M.L. Lo, F. Pezzetti, C. Rubini, and A. Girardi et al. MicroRNA expression profiling of oral carcinoma identifies new markers of tumor progression Int J Immunopathol Pharmacol 23 4 2010 1229 1234
13. Y.X. Wang, X.Y. Zhang, B.F. Zhang, C.Q. Yang, X.M. Chen, and H.J. Gao Initial study of microRNA expression profiles of colonic cancer without lymph node metastasis J Dig Dis 11 1 2010 50 54
14. P. Faltejskova, M. Svoboda, K. Srutova, J. Mlcochova, A. Besse, and J. Nekvindova et al. Identification and functional screening of microRNAs highly deregulated in colorectal cancer J Cell Mol Med 16 11 2012 2655 2666
15. Y. Yang, H. Li, F. Zhang, H. Shi, T. Zhen, and S. Dai et al. Clinical and biological significance of hepatoma-derived growth factor in Ewing's sarcoma J Pathol 231 3 2013 323 334
16. F. Zhang, F. Meng, H. Li, Y. Dong, W. Yang, and A. Han Suppression of retinoid X receptor alpha and aberrant beta-catenin expression significantly associates with progression of colorectal carcinoma Eur J Cancer 47 13 2011 2060 2067
17. H. Deng, Y. Guo, H. Song, B. Xiao, W. Sun, and Z. Liu et al. MicroRNA-195 and microRNA-378 mediate tumor growth suppression by epigenetical regulation in gastric cancer Gene 518 2 2013 351 359
18. K. Skrzypek, M. Tertil, S. Golda, M. Ciesla, K. Weglarczyk, and G. Collet et al. Interplay between heme oxygenase-1 and miR-378 affects non-small cell lung carcinoma growth, vascularization, and metastasis Antioxid Redox Signal 19 7 2013 644 660
19. â̂ -, miR-191, miR-337-3p and miR-378) as potential biomarkers in renal cell carcinoma Cancer Epidemiol 36 4 2012 391 394
20. I. Knezevic, A. Patel, N.R. Sundaresan, M.P. Gupta, R.J. Solaro, and R.S. Nagalingam et al. A novel cardiomyocyte-enriched microRNA, miR-378, targets insulin-like growth factor 1 receptor: implications in postnatal cardiac remodeling and cell survival J Biol Chem 287 16 2012 12913 12926
21. D.Y. Lee, Z. Deng, C.H. Wang, and B.B. Yang MicroRNA-378 promotes cell survival, tumor growth, and angiogenesis by targeting SuFu and Fus-1 expression Proc Natl Acad Sci U S A 104 51 2007 20350 20355